Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

PEPFAR has been a lifeline in Ukraine. Now it’s under threat

In Ukraine, a little bit of good news can go a long way, and the lifesaving work being done as a result of the President’s Emergency

December 1, 2023

ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI

ATLANTA — Those in cardiovascular medicine can anticipate changes in clinical practice for acute myocardial infarction (MI) following this weekend’s American College of Cardiology (ACC)

April 5, 2024

Donanemab may offer new hope for people with early Alzheimer’s disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.